Document Detail


A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate clinical efficacy of a fixed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder.
MedLine Citation:
PMID:  17486686     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Valerian and hops are traditionally used as sleep aids. Since the fixed extract combination (Ze 91019) as a whole is considered the active compound, the clinical efficacy must be demonstrated for this extract combination. The present clinical study aimed to demonstrate superiority of the fixed extract combination in comparison with placebo in patients suffering from non-organic insomnia (ICD 10, F 51.0-51.2). Objective sleep parameters were registered by means of a transportable home recorder system (QUISI). The primary outcome was the reduction in sleep latency (SL2) which had to be prolonged at baseline (>/=30 min) as an inclusion criteria. The treatment period lasted for 4 weeks with either placebo, single valerian extract (Ze 911) or the fixed valerian hops extract combination (Ze 91019). The amount of the single valerian extract was identical to that amount contained in the fixed extract combination, i.e. 500 mg valerian extract siccum. In the extract combination 120 mg hops extract siccum was added. Both the extracts were prepared with 45% methanol m/m with a drug-extract ratio of 5.3:1 (valerian) and 6.6:1 (hops), respectively. The fixed extract combination was significantly superior to the placebo in reducing the sleep latency whilst the single valerian extract failed to be superior to the placebo. The result underlined the plausibility for adding hops extract to the valerian extract.
Authors:
U Koetter; E Schrader; R Käufeler; A Brattström
Related Documents :
6531036 - Psoralens and ocular effects in humans.
14764356 - The development of sleep in persons undergoing cataract surgery.
7680186 - Anterior hyaloidal fibrovascular proliferation after extracapsular cataract extraction ...
25156346 - Are confusional arousals pathological?
22119526 - Rem sleep depotentiates amygdala activity to previous emotional experiences.
23007096 - Continuity and change in infants' sleep from 8 to 14 months: a longitudinal actigraphy ...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Phytotherapy research : PTR     Volume:  21     ISSN:  0951-418X     ISO Abbreviation:  Phytother Res     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-08-27     Completed Date:  2007-10-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8904486     Medline TA:  Phytother Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  847-51     Citation Subset:  IM    
Affiliation:
Max Zeller Söhne AG, CH-8590 Romanshorn, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adult
Double-Blind Method
Drug Therapy, Combination
Female
Humans
Humulus*
Hypnotics and Sedatives / administration & dosage,  therapeutic use*
Male
Phytotherapy*
Plant Extracts / administration & dosage,  therapeutic use*
Prospective Studies
Severity of Illness Index
Sleep Initiation and Maintenance Disorders / drug therapy*
Treatment Outcome
Valerian*
Chemical
Reg. No./Substance:
0/Hypnotics and Sedatives; 0/Plant Extracts

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of acute administration of hydroalcohol extract of Ilex paraguariensis St Hilaire (Aquifoliac...
Next Document:  Prophylactic effect of flaxseed oil against radiation-induced hepatotoxicity in mice.